Cargando…

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists

[Image: see text] While screening off-target effects of rigid (N)-methanocarba-adenosine 5′-methylamides as A(3) adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). In an effort to increase OR and decrease AR affinity by str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tosh, Dilip K., Ciancetta, Antonella, Mannes, Philip, Warnick, Eugene, Janowsky, Aaron, Eshleman, Amy J., Gizewski, Elizabeth, Brust, Tarsis F., Bohn, Laura M., Auchampach, John A., Gao, Zhan-Guo, Jacobson, Kenneth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210068/ https://www.ncbi.nlm.nih.gov/pubmed/30411015 http://dx.doi.org/10.1021/acsomega.8b01237

Ejemplares similares

Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A(3) Adenosine Receptor Agonists
por: Tosh, Dilip K., et al.
Publicado: (2016)

Bitopic fluorescent antagonists of the A(2A) adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congeners
por: Duroux, Romain, et al.
Publicado: (2017)

In Vivo Phenotypic Screening for Treating Chronic Neuropathic Pain: Modification of C2-Arylethynyl Group of Conformationally Constrained A(3) Adenosine Receptor Agonists
por: Tosh, Dilip K., et al.
Publicado: (2014)

Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A(3 )adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse hearts
por: Wan, Tina C, et al.
Publicado: (2011)

Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
por: Jacobson, Kenneth A., et al.
Publicado: (2019)

Structural Probing and Molecular Modeling of the A(3) Adenosine Receptor: A Focus on Agonist Binding
por: Ciancetta, Antonella, et al.
Publicado: (2017)

Non-Nucleoside Agonists of the Adenosine Receptors: An Overview
por: Dal Ben, Diego, et al.
Publicado: (2019)

GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A(2A) Adenosine Receptor
por: Shiriaeva, Anna, et al.
Publicado: (2022)

A(3) Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
por: Spinaci, Andrea, et al.
Publicado: (2022)

Species dependence of A(3) adenosine receptor pharmacology and function
por: Gao, Zhan-Guo, et al.
Publicado: (2022)

Adenosine A(3) Receptor (A(3)AR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice
por: Sgambellone, Silvia, et al.
Publicado: (2022)

Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A(2B) adenosine receptor
por: Dal Ben, Diego, et al.
Publicado: (2013)

Nucleoside conjugates of quantum dots for characterization of G protein-coupled receptors: strategies for immobilizing A(2A )adenosine receptor agonists
por: Das, Arijit, et al.
Publicado: (2010)

Physiology and effects of nucleosides in mice lacking all four adenosine receptors
por: Xiao, Cuiying, et al.
Publicado: (2019)

Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
por: Klutz, Athena M, et al.
Publicado: (2008)

Structural Probing of Off-Target G Protein-Coupled Receptor Activities within a Series of Adenosine/Adenine Congeners
por: Paoletta, Silvia, et al.
Publicado: (2014)

The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?
por: Marzagalli, Rubina, et al.
Publicado: (2015)

Synthesis and Anti-Renal Fibrosis Activity of Conformationally Locked Truncated 2-Hexynyl-N(6)-Substituted-(N)-Methanocarba-nucleosides as A(3) Adenosine Receptor Antagonists and Partial Agonists
por: Nayak, Akshata, et al.
Publicado: (2014)

John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors()
por: Jacobson, Kenneth A., et al.
Publicado: (2014)

Structural and Energetic Effects of A(2A) Adenosine Receptor Mutations on Agonist and Antagonist Binding
por: Keränen, Henrik, et al.
Publicado: (2014)

Adenosine Receptors as Neuroinflammation Modulators: Role of A(1) Agonists and A(2A) Antagonists
por: Martí Navia, Aleix, et al.
Publicado: (2020)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Targeting the A(3) adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice
por: Singh, Anand Kumar, et al.
Publicado: (2022)

Development of selective agonists and antagonists of P2Y receptors
por: Jacobson, Kenneth A., et al.
Publicado: (2008)

Adenosine Receptor Agonists Exhibit Anti-Platelet Effects and the Potential to Overcome Resistance to P2Y(12) Receptor Antagonists
por: Wolska, Nina, et al.
Publicado: (2019)

The Role of Adenosine Receptor Agonists in Regulation of Hematopoiesis
por: Hofer, Michal, et al.
Publicado: (2011)

Structure activity relationship of novel antiviral nucleosides against Enterovirus A71
por: Tosh, Dilip K., et al.
Publicado: (2020)

Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
por: Montoya, Marhiah C., et al.
Publicado: (2018)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs
por: Jacobson, Kenneth A., et al.
Publicado: (2020)

Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium: Role of Ectonucleotidases and Adenosine A(2B) Receptors
por: Eltzschig, Holger K., et al.
Publicado: (2003)

Development of a Radiofluorinated Adenosine A(2B) Receptor Antagonist as Potential Ligand for PET Imaging
por: Lindemann, Marcel, et al.
Publicado: (2020)

Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing
por: Taylor, Lewis, et al.
Publicado: (2014)

Effect of Adenosine Receptor Antagonists on Adenosine-Pretreated PC12 Cells Exposed to Paraquat
por: Shang, Liangcheng, et al.
Publicado: (2022)

Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020)

Convergent synthesis of 2-thioether-substituted (N)-methanocarba-adenosines as purine receptor agonists
por: Suresh, R. Rama, et al.
Publicado: (2021)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
por: Lattanzi, Roberta, et al.
Publicado: (2022)

Pharmacological characterisation of novel adenosine A(3) receptor antagonists
por: Barkan, Kerry, et al.
Publicado: (2020)

Impact of an Adenosine A(2A) Receptor Agonist and Antagonist on Binding of the Dopamine D(2) Receptor Ligand [(11)C]raclopride in the Rodent Striatum
por: Prasad, Kavya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4c6lcegb4ntu48s3ucft98lni1